Announcements Trials

Browse Landscape

Phase

Status

Unknown 9 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 1

Interventions

pembrolizumab 29 Carboplatin 27 durvalumab 21 Specimen Handling 21 Pemetrexed 18 Cisplatin 17 Paclitaxel 16 atezolizumab 15 Nivolumab 15 Magnetic Resonance Spectroscopy 15 osimertinib 11 Radiosurgery 11 Radiotherapy 10 Immunoglobulin G 10 Etoposide 10 Docetaxel 10 Disulfides 10 Radiation 9 Taxes 8 Gemcitabine 8 Biopsy 8 Blood Specimen Collection 7 Standard of Care 6 Practice Guidelines as Topic 6 Ipilimumab 6 Surveys and Questionnaires 5 Platinum 5 Bronchoscopy 5 Bevacizumab 5 Ramucirumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lung Neoplasms × aumolertinib × Clear all

NCT04841811 2026-05-22

APPROACH

Guangdong Association of Clinical Trials

Phase 3 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡